Co-Diagnostics, Inc. — Director's Dealing 2020

Nov 24, 2020

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Co-Diagnostics, Inc. (CODX)
CIK: 0001692415
Period of Report: 2020-11-23

Reporting Person: BENSON REED L (CFO and Secretary)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2020-11-23	Restricted Stock Units	$	A	27500	Acquired		Common Stock (27500)	Direct

Footnotes

F1: Granted pursuant to Issuer's 2015 Long Term Incentive Plan, as amended. Each restricted stock unit ("RSU") represents the contingent right to receive, upon vesting, one share
of the Issuer's common stock.

F2: RSU vests in equal installments in 6 equal installments commencing on the six month anniversary of the date of grant and every six months thereafter.